REVIEW article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1614429
This article is part of the Research TopicReviews in Ethnopharmacology: 2025View all 33 articles
Advances of Paeoniflorin in Depression: the Molecular Mechanism and Formula Application
Provisionally accepted- 1The People‘s Hospital of Zhongjiang, Deyang, China
- 2Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China
- 3Nanchong Central Hospital, Nanchong, Sichuan Province, China
- 4Molecular Urooncology Dep. of Urology Klinikum rechts der Isar Technical University of Munich Ismaningerstr, München, Germany
- 5Xichang People's Hospital, Xichang, Sichuan, China
- 6West China School of Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Paeoniflorin (PF), is widely present in plants of the Paeonia lactiflora Pall. [Paeoniaceae, Paeonia lactiflora root], and is a bioactive metabolite with both medicinal and nutritional properties. In recent years, numerous preclinical studies have shown that PF has preventive and therapeutic effects on various neurological diseases, particularly in the prevention and treatment of depression. Additionally, some classic traditional Chinese medicine formulas containing PF, such as Xiaoyao San, Chaihu Shugan San, and Sini San, have been proven to significantly improve depressive symptoms. However, the antidepressant mechanisms of PF and its containing classic traditional Chinese medicine formulas are not yet fully understood. PF, as a natural glycoside metabolite with a wide margin of safety and good tolerance, exhibits certain toxicity at high concentrations. The differences in standardized methods between the traditional formulations, such as extraction processes, dosages, and inherent metabolite variability in formulations, may affect the interpretation of results and clinical applications. Therefore, this article reviews the antidepressant mechanisms of PF from the perspectives of inhibiting the hypothalamic-pituitary-adrenal axis, increasing the levels of monoamine neurotransmitters, suppressing oxidative stress and apoptosis, regulating calcium homeostasis, inhibiting neuroinflammation, modulating mitochondrial function, regulating cellular autophagy, and increasing the levels of brain-derived neurotrophic factor, and elucidates the antidepressant effects and mechanisms of traditional Chinese medicine formulations containing PF. Additionally, we describe the physicochemical properties, toxinology, pharmacokinetic characteristics, and the transformation of PF in vivo. This review may contribute to the application of PF and its formulations in depression.
Keywords: paeoniflorin, Medicine Formula, Depression, Pharmacological mechanism, pharmacokinetics
Received: 18 Apr 2025; Accepted: 20 Aug 2025.
Copyright: © 2025 Hou, Wei, Zhu, quan, Feng, Li, Bian and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yuan Bian, Xichang People's Hospital, Xichang, 615000, Sichuan, China
Hong Li, West China School of Medicine, West China Hospital, Sichuan University, Chengdu, 610000, Sichuan Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.